Drug Shortage Report for PROQUAD

Last updated on 2024-04-27 History
Report ID 221447
Drug Identification Number 02399229
Brand name PROQUAD
Common or Proper name measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s) 3.99Log10 PFU 3.00Log10 TCID50 4.30Log10 TCID50 3.00Log10 TCID50
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10 X 1 DOSE VIAL
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-05-10
Actual start date
Estimated end date 2024-08-30
Actual end date
Shortage status Anticipated shortage
Updated date 2024-04-27
Company comments Remaining doses are reserved for the public immunization program
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2024-04-27 French Compare
v21 2024-04-27 English Compare
v20 2024-04-27 English Compare
v19 2024-04-13 French Compare
v18 2024-04-13 English Compare
v17 2024-04-13 French Compare
v16 2024-04-04 English Compare
v15 2024-03-28 French Compare
v14 2024-03-28 English Compare
v13 2024-03-22 French Compare
v12 2024-03-22 English Compare
v11 2024-03-15 English Compare
v10 2024-03-08 English Compare
v9 2024-03-07 French Compare
v8 2024-03-07 English Compare
v7 2024-03-06 French Compare
v6 2024-03-06 English Compare
v5 2024-03-06 French Compare
v4 2024-03-06 French Compare
v3 2024-03-06 English Compare

Showing 1 to 20 of 22